Long-Term Safety and Efficacy of Empagliflozin, Sitagliptin, and Metformin: An active-controlled, parallel-group, randomized, 78-week open-label extension study in patients with ty...

por Ferrannini, Ele, Berk, Andreas, Hantel, Stefan, Pinnetti, Sabine, Hach, Thomas, Woerle, Hans J., Broedl, Uli C.
Publicado 2013

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus

por Heise, Tim, Seman, Leo, Macha, Sreeraj, Jones, Peter, Marquart, Alexandra, Pinnetti, Sabine, Woerle, Hans J., Dugi, Klaus
Publicado 2013

Effects of Adding Linagliptin to Basal Insulin Regimen for Inadequately Controlled Type 2 Diabetes: A ≥52-week randomized, double-blind study

por Yki-Järvinen, Hannele, Rosenstock, Julio, Durán-Garcia, Santiago, Pinnetti, Sabine, Bhattacharya, Sudipta, Thiemann, Sandra, Patel, Sanjay, Woerle, Hans-Juergen
Publicado 2013

Clinical trial simulations in pulmonary fibrosis: patient-focused insights and adaptations

por Jones, Steve, Flewett, Maxine, Flewett, Ron, Lee, Sharon, Vick, Bill, Thompson, Milla, Pinnetti, Sabine, Zoz, Donald F., Hoffmann-Vold, Anna-Maria, Kreuter, Michael, Maher, Toby M.
Publicado 2023